Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BioGaia AB (publ)

BGLAF
Current price
11.75 USD 0 USD (0.00%)
Last closed 116.9 SEK
ISIN SE0017769995
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange ST
Capitalization 11 823 227 690 SEK
Yield for 12 month +25.60 %
1Y
3Y
5Y
10Y
15Y
BGLAF
21.11.2021 - 28.11.2021

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden. Address: Kungsbroplan 3, Stockholm, Sweden, 112 27

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1 654.89 SEK

P/E ratio

29.5226

Dividend Yield

1.62 %

Current Year

+1 289 664 546 SEK

Last Year

+1 098 132 588 SEK

Current Quarter

+382 095 048 SEK

Last Quarter

+367 848 621 SEK

Current Year

+945 175 997 SEK

Last Year

+797 698 349 SEK

Current Quarter

+282 542 161 SEK

Last Quarter

+264 430 242 SEK

Key Figures BGLAF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 491 223 137 SEK
Operating Margin TTM 36.76 %
PE Ratio 29.5226
Return On Assets TTM 14.8 %
PEG Ratio
Return On Equity TTM 23.23 %
Wall Street Target Price 1 654.89 SEK
Revenue TTM 1 362 159 956 SEK
Book Value 15.52 SEK
Revenue Per Share TTM
Dividend Share 1.89 SEK
Quarterly Revenue Growth YOY 21.9 %
Dividend Yield 1.62 %
Gross Profit TTM 797 697 351 SEK
Earnings per share 3.96 SEK
Diluted Eps TTM 3.96 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 37.8 %
Profit Margin 29.34 %

Dividend Analytics BGLAF

Dividend growth over 5 years

68 %

Continuous growth

3 years

Payout Ratio 5 years average

34 %

Dividend History BGLAF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 1.9
Ex Dividend Date 08.05.2024
Forward Annual Dividend Yield 1.62 %
Last Split Factor 5:1
Payout Ratio 47.62 %
Last Split Date 18.05.2022
Dividend Date

Stock Valuation BGLAF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 29.5226
Forward PE
Enterprise Value Revenue 7.9439
Price Sales TTM 8.6798
Enterprise Value EBITDA 20.1353
Price Book MRQ 7.5452

Financials BGLAF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BGLAF

For 52 weeks

89.63 SEK 135.88 SEK
50 Day MA 122.49 SEK
Shares Short Prior Month
200 Day MA 118.62 SEK
Short Ratio
Shares Short
Short Percent